British drugmaker Indivior got the green light from US regulators to sell its schizophrenia drug Perseris — a relief, no doubt, considering the company’s ongoing exclusivity war over its staple drug Suboxone.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,